相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The role of gender in a large international OCD sample: A Report from the International College of Obsessive-Compulsive Spectrum Disorders (ICOCS) Network
Beatrice Benatti et al.
COMPREHENSIVE PSYCHIATRY (2022)
A nationwide nested case-control study of new-onset obsessive-compulsive disorder following antipsychotics use in schizophrenia
Chun Il Park et al.
ACTA PSYCHIATRICA SCANDINAVICA (2021)
Minocycline alleviates depression-like symptoms by rescuing decrease in neurogenesis in dorsal hippocampus via blocking microglia activation/phagocytosis
Ben Bassett et al.
BRAIN BEHAVIOR AND IMMUNITY (2021)
First manic/hypomanic episode in obsessive-compulsive disorder patients treated with antidepressants: A systematic review
Sara Bertolin et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2021)
Ketamine increases activity of a fronto-striatal projection that regulates compulsive behavior in SAPAP3 knockout mice
Gwynne L. Davis et al.
NATURE COMMUNICATIONS (2021)
Defining and Addressing Gaps in Care for Obsessive-Compulsive Disorder in the United States
Meredith S. Senter et al.
PSYCHIATRIC SERVICES (2021)
Lithium: a potential therapeutic strategy in obsessive-compulsive disorder by targeting the canonical WNT/β pathway
Alexandre Vallee et al.
TRANSLATIONAL PSYCHIATRY (2021)
Tolcapone in obsessive-compulsive disorder: a randomized double-blind placebo-controlled crossover trial
Jon E. Grant et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2021)
A phase 2 trial of inhaled nitrous oxide for treatment-resistant major depression
Peter Nagele et al.
SCIENCE TRANSLATIONAL MEDICINE (2021)
Long-term Amelioration of OCD Symptoms in a Patient with Chronic Consumption of Psilocybin-containing Mushrooms
Agustin Lugo-Radillo et al.
JOURNAL OF PSYCHOACTIVE DRUGS (2021)
Four-year course of quality of life and obsessive-compulsive disorder
Karin C. P. Remmerswaal et al.
SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY (2020)
Pregabalin augmentation for resistant obsessive-compulsive disorder: a double-blind placebo-controlled clinical trial
Arash Mowla et al.
CNS SPECTRUMS (2020)
Natural compulsive-like behaviour in the deer mouse (Peromyscus maniculatus bairdii) is associated with altered gut microbiota composition
Isabella M. Scheepers et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2020)
Herbal medicines and phytochemicals for obsessive-compulsive disorder
Zahra Ayati et al.
PHYTOTHERAPY RESEARCH (2020)
The gut microbiome and inflammation in obsessive-compulsive disorder patients compared to age- and sex-matched controls: a pilot study
J. Turna et al.
ACTA PSYCHIATRICA SCANDINAVICA (2020)
Acute effects of cannabinoids on symptoms of obsessive-compulsive disorder: A human laboratory study
Reilly R. Kayser et al.
DEPRESSION AND ANXIETY (2020)
Clinical advances in obsessive-compulsive disorder: a position statement by the International College of Obsessive-Compulsive Spectrum Disorders
Naomi A. Fineberg et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2020)
Ketamine and nitrous oxide: The evolution of NMDA receptor antagonists as antidepressant agents
Molly C. Kalmoe et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2020)
Clinical utility of repeated intravenous ketamine treatment for resistant obsessive-compulsive disorder
Lavanya P. Sharma et al.
ASIAN JOURNAL OF PSYCHIATRY (2020)
Cannabis Improves Obsessive-Compulsive Disorder-Case Report and Review of the Literature
Natalia Szejko et al.
FRONTIERS IN PSYCHIATRY (2020)
Metacognitive beliefs predict early response to pharmacological treatment in patients with obsessive-compulsive disorder
Chun Il Park et al.
PSYCHOPHARMACOLOGY (2020)
But first, coffee: The roles of arousal and inhibition in the resistance of compulsive cleansing in individuals with high contamination fears
Hadar Naftalovich et al.
JOURNAL OF ANXIETY DISORDERS (2020)
Women Are at Greater Risk of OCD Than Men: A Meta-Analytic Review of OCD Prevalence Worldwide
Emily J. Fawcett et al.
JOURNAL OF CLINICAL PSYCHIATRY (2020)
Cannabinoid Augmentation of Exposure-Based Psychotherapy for Obsessive-Compulsive Disorder
Reilly R. Kayser et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2020)
Augmentation agents to serotonin reuptake inhibitors for treatment-resistant obsessive-compulsive disorder: A network meta-analysis
Dong-Dong Zhou et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2019)
The erring brain: Error-related negativity as an endophenotype for OCD-A review and meta-analysis
Anja Riesel
PSYCHOPHYSIOLOGY (2019)
Duration of untreated illness and response to SRI treatment in Obsessive-Compulsive Disorder
Umberto Albert et al.
EUROPEAN PSYCHIATRY (2019)
Comparing the efficacy of ondansetron and granisetron augmentation in treatment-resistant obsessive-compulsive disorder: a randomized double-blind placebo-controlled study
Mojtaba Sharafkhah et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2019)
Comparative efficacy and tolerability of antipsychotics as augmentations in adults with treatment-resistant obsessive-compulsive disorder: A network meta-analysis
Dong-Dong Zhou et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2019)
Epidemiological and Clinical Gender Differences in OCD
Brittany M. Mathes et al.
CURRENT PSYCHIATRY REPORTS (2019)
Dopaminergic drug treatment remediates exaggerated cingulate prediction error responses in obsessive-compulsive disorder
Graham K. Murray et al.
PSYCHOPHARMACOLOGY (2019)
Comorbidity of Obsessive-Compulsive Disorder and Schizotypal Personality Disorder: Clinical Response and Treatment Resistance to Pharmacotherapy in a 3-Year Follow-Up Naturalistic Study
Francesco Perris et al.
FRONTIERS IN PSYCHIATRY (2019)
Level of Insight in Patients With Obsessive-Compulsive Disorder: An Exploratory Comparative Study Between Patients With Good Insight and Poor Insight
Richard Chuquel Silveira de Avila et al.
FRONTIERS IN PSYCHIATRY (2019)
Meta-Analysis of Placebo Response in Adult Antidepressant Trials
Fenghua Li et al.
CNS DRUGS (2019)
Minocycline alters behavior, microglia and the gut microbiome in a trait-anxiety-dependent manner
Anna K. Schmidtner et al.
TRANSLATIONAL PSYCHIATRY (2019)
Combined fluvoxamine and extended-release methylphenidate improved treatment response compared to fluvoxamine alone in patients with treatment-refractory obsessive-compulsive disorder: A randomized double-blind, placebo-controlled study
Huirong Zheng et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2019)
Immune Aberrations in Obsessive-Compulsive Disorder: a Systematic Review and Meta-analysis
Theodore D. Cosco et al.
MOLECULAR NEUROBIOLOGY (2019)
COX-2 inhibition rescues depression-like behaviors via suppressing glial activation, oxidative stress and neuronal apoptosis in rats
Qiqi Song et al.
NEUROPHARMACOLOGY (2019)
Augmentation With Memantine in Obsessive-Compulsive Disorder
Chittaranjan Andrade
JOURNAL OF CLINICAL PSYCHIATRY (2019)
Treatment of Gilles de la Tourette Syndrome with Cannabis-Based Medicine: Results from a Retrospective Analysis and Online Survey
Leonie M. Milosev et al.
CANNABIS AND CANNABINOID RESEARCH (2019)
A total-population multigenerational family clustering study of autoimmune diseases in obsessive-compulsive disorder and Tourette's/chronic tic disorders
D. Mataix-Cols et al.
MOLECULAR PSYCHIATRY (2018)
Memantine Augmentation Improves Symptoms in Serotonin Reuptake Inhibitor-Refractory Obsessive-Compulsive Disorder: A Randomized Controlled Trial
Atieh Modarresi et al.
PHARMACOPSYCHIATRY (2018)
Gut Microbiota Profiling and Gut-Brain Crosstalk in Children Affected by Pediatric Acute-Onset Neuropsychiatric Syndrome and Pediatric Autoimmune Neuropsychiatric Disorders Associated With Streptococcal Infections
Andrea Quagliariello et al.
FRONTIERS IN MICROBIOLOGY (2018)
Are Mentalizing Abilities and Insight Related to the Severity of Obsessive-Compulsive Disorder
Leman Inanc et al.
PSYCHIATRY INVESTIGATION (2018)
Challenges in Testing Intranasal Ketamine in Obsessive-Compulsive Disorder
Carolyn I. Rodriguez et al.
JOURNAL OF CLINICAL PSYCHIATRY (2017)
Randomized, Double-Blind, Placebo-Controlled Trial of N-Acetylcysteine Augmentation for Treatment-Resistant Obsessive-Compulsive Disorder
Daniel L. C. Costa et al.
JOURNAL OF CLINICAL PSYCHIATRY (2017)
Intranasal Ketamine and Cognitive-Behavioral Therapy for Treatment-Refractory Obsessive-Compulsive Disorder
Thomas G. Adams et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2017)
Is Ondansetron Augmentation Effective in Obsessive-Compulsive Disorder?
Bangalore G. Kalyani et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2017)
Memantine as an Adjuvant Treatment for Obsessive Compulsive Symptoms in Manic Phase of Bipolar Disorder: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
Ali Sahraian et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2017)
Preliminary Evidence on Cannabis Effectiveness and Tolerability for Adults With Tourette Syndrome
Elia Abi-Jaoude et al.
JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES (2017)
Buprenorphine augmentation improved symptoms of OCD, compared to placebo - Results from a randomized, double-blind and placebo-controlled clinical trial
Mohammad Ahmadpanah et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2017)
A Consensus Statement on the Use of Ketamine in the Treatment of Mood Disorders
Gerard Sanacora et al.
JAMA PSYCHIATRY (2017)
Inflammation in the Neurocircuitry of Obsessive-Compulsive Disorder
Sophia Attwells et al.
JAMA PSYCHIATRY (2017)
Intravenous Clomipramine for Treatment-Resistant Obsessive-Compulsive Disorder
Wael Karameh Karameh et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2016)
N-acetylcysteine augmentation therapy for moderate-to-severe obsessive-compulsive disorder: randomized, double-blind, placebo-controlled trial
K. Paydary et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2016)
Tic-Related Versus Tic-Free Obsessive-Compulsive Disorder: Clinical Picture and 2-Year Natural Course
Froukje E. de Vries et al.
JOURNAL OF CLINICAL PSYCHIATRY (2016)
Can Exposure-Based CBT Extend the Effects of Intravenous Ketamine in Obsessive-Compulsive Disorder? An Open-Label Trial
Carolyn I. Rodriguez et al.
JOURNAL OF CLINICAL PSYCHIATRY (2016)
Pharmacology of dextromethorphan: Relevance to dextromethorphan/quinidine (Nuedexta®) clinical use
Charles P. Taylor et al.
PHARMACOLOGY & THERAPEUTICS (2016)
Minocycline combination therapy with fluvoxamine in moderate-to-severe obsessive-compulsive disorder: A placebo-controlled, double-blind, randomized trial
Sophia Esalatmanesh et al.
PSYCHIATRY AND CLINICAL NEUROSCIENCES (2016)
Riluzole in augmentation of fluvoxamine for moderate to severe obsessive-compulsive disorder: Randomized, double-blind, placebo-controlled study
Sahra Emamzadehfard et al.
PSYCHIATRY AND CLINICAL NEUROSCIENCES (2016)
Towards an international expert consensus for defining treatment response, remission, recovery and relapse in obsessive-compulsive disorder
David Mataix-Cols et al.
WORLD PSYCHIATRY (2016)
Ketamine and Other NMDA Antagonists: Early Clinical Trials and Possible Mechanisms in Depression
D. Jeffrey Newport et al.
AMERICAN JOURNAL OF PSYCHIATRY (2015)
Nitrous Oxide for Treatment-Resistant Major Depression: A Proof-of-Concept Trial
Peter Nagele et al.
BIOLOGICAL PSYCHIATRY (2015)
N-Acetyl Cysteine (NAC) in the Treatment of Obsessive-Compulsive Disorder: A 16-Week, Double-Blind, Randomised, Placebo-Controlled Study
Jerome Sarris et al.
CNS DRUGS (2015)
DISSECTING OCD CIRCUITS: FROM ANIMAL MODELS TO TARGETED TREATMENTS
Susanne E. Ahmari et al.
DEPRESSION AND ANXIETY (2015)
A review of the current nomenclature for psychotropic agents and an introduction to the Neuroscience-based Nomenclature
Joseph Zohar et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2015)
Antipsychotic Augmentation of Serotonin Reuptake Inhibitors in Treatment-Resistant Obsessive-Compulsive Disorder: An Update Meta-Analysis of Double-Blind, Randomized, Placebo-Controlled Trials
Markus Dold et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2015)
The prevalence and predictors of comorbid bipolar disorder and obsessive-compulsive disorder: A systematic review and meta-analysis
A. Amerio et al.
JOURNAL OF AFFECTIVE DISORDERS (2015)
Riluzole Augmentation in Treatment-Refractory Obsessive-Compulsive Disorder: A Pilot Randomized Placebo-Controlled Trial
Christopher Pittenger et al.
JOURNAL OF CLINICAL PSYCHIATRY (2015)
Ondansetron Augmentation of Serotonin Reuptake Inhibitors as a Treatment Strategy in Obsessive-Compulsive Disorder
Chittaranjan Andrade
JOURNAL OF CLINICAL PSYCHIATRY (2015)
Topiramate augmentation in a patient with obsessive-compulsive disorder
Michael Van Ameringen et al.
JOURNAL OF PSYCHIATRY & NEUROSCIENCE (2015)
Pindolol augmentation of selective serotonin reuptake inhibitors and clomipramine for the treatment of obsessive-compulsive disorder: A meta-analysis
Sean A. Sassano-Higgins et al.
JOURNAL OF PHARMACOLOGY & PHARMACOTHERAPEUTICS (2015)
Role of Lamotrigine Augmentation in Treatment-Resistant Obsessive Compulsive Disorder: A Retrospective Case Review from South Asia
Arshad Hussain et al.
INDIAN JOURNAL OF PSYCHOLOGICAL MEDICINE (2015)
Anti-basal ganglia antibodies in primary obsessive-compulsive disorder: systematic review and meta-analysis
Daniel M. Pearlman et al.
BRITISH JOURNAL OF PSYCHIATRY (2014)
Ondansetron or placebo in the augmentation of fluvoxamine response over 8 weeks in obsessive-compulsive disorder
Mahnaz Heidari et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2014)
12-Week, Placebo-Controlled Trial of Add-on Riluzole in the Treatment of Childhood-Onset Obsessive-Compulsive Disorder
Paul J. Grant et al.
NEUROPSYCHOPHARMACOLOGY (2014)
D2 and D3 dopamine receptor affinity predicts effectiveness of antipsychotic drugs in obsessive-compulsive disorders: a metaregression analysis
Deborah Ducasse et al.
PSYCHOPHARMACOLOGY (2014)
Second Generation Antipsychotic-Induced Obsessive-Compulsive Symptoms in Schizophrenia: A Review of the Experimental Literature
Trehani M. Fonseka et al.
CURRENT PSYCHIATRY REPORTS (2014)
Psilocybin and Obsessive Compulsive Disorder
James Allen Wilcox
JOURNAL OF PSYCHOACTIVE DRUGS (2014)
Pharmacotherapy of obsessive-compulsive disorder: Evidence-based treatment and beyond
Naomi A. Fineberg et al.
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2013)
Plant-Based Medicines for Anxiety Disorders, Part 2: A Review of Clinical Studies with Supporting Preclinical Evidence
Jerome Sarris et al.
CNS DRUGS (2013)
Quality of life in obsessive compulsive disorder
Alexandra S. Macy et al.
CNS SPECTRUMS (2013)
CLINICAL PREDICTORS OF LONG-TERM OUTCOME IN OBSESSIVE-COMPULSIVE DISORDER
Ewgeni Jakubovski et al.
DEPRESSION AND ANXIETY (2013)
Dopaminergic activity in Tourette syndrome and obsessive-compulsive disorder
Damiaan Denys et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2013)
Antipsychotic augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a meta-analysis of double-blind, randomized, placebo-controlled trials
Markus Dold et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2013)
Double-Blind, Placebo-Controlled, Pilot Trial of Paliperidone Augmentation in Serotonin Reuptake Inhibitor-Resistant Obsessive-Compulsive Disorder
Eric A. Storch et al.
JOURNAL OF CLINICAL PSYCHIATRY (2013)
Memantine add-on in moderate to severe obsessive-compulsive disorder: Randomized double-blind placebo-controlled study
Ali Ghaleiha et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2013)
Two cases of delayed-onset suicidal ideation, dysphoria and anxiety after ketamine infusion in patients with obsessive-compulsive disorder and a history of major depressive disorder
Mark J. Niciu et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2013)
Randomized Controlled Crossover Trial of Ketamine in Obsessive-Compulsive Disorder: Proof-of-Concept
Carolyn I. Rodriguez et al.
NEUROPSYCHOPHARMACOLOGY (2013)
In a double-blind, randomized and placebo-controlled trial, adjuvant memantine improved symptoms in inpatients suffering from refractory obsessive-compulsive disorders (OCD)
Mohammad Haghighi et al.
PSYCHOPHARMACOLOGY (2013)
Buprenorphine augmentation in the treatment of refractory obsessive-compulsive disorder
Malcolm B. Liddell et al.
THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY (2013)
THE EFFECT OF PERSONALITY DISORDERS ON TREATMENT OUTCOMES IN PATIENTS WITH OBSESSIVE-COMPULSIVE DISORDERS
Nicola Thiel et al.
JOURNAL OF PERSONALITY DISORDERS (2013)
Effects of Ketamine in Treatment-Refractory Obsessive-Compulsive Disorder
Michael H. Bloch et al.
BIOLOGICAL PSYCHIATRY (2012)
Elucidating the Mechanism of Action of Pregabalin α2δ as a Therapeutic Target in Anxiety
Juan-Antonio Mico et al.
CNS DRUGS (2012)
N-Acetylcysteine Add-On Treatment in Refractory Obsessive-Compulsive Disorder A Randomized, Double-Blind, Placebo-Controlled Trial
Hamid Afshar et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2012)
Comparative neuropsychology of adult obsessive-compulsive disorder and attention deficit/hyperactivity disorder: Implications for a novel executive overload model of OCD
Amitai Abramovitch et al.
JOURNAL OF NEUROPSYCHOLOGY (2012)
Lamotrigine augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a double-blind, placebo-controlled study
Antonio Bruno et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2012)
Obsessive-Compulsive Disorder, Impulse Control Disorders and Drug Addiction Common Features and Potential Treatments
Leonardo F. Fontenelle et al.
DRUGS (2011)
Pregabalin augmentation in treatment-resistant obsessive-compulsive disorder
Panagiotis Oulis et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2011)
Double-Blind, Placebo-Controlled Trial of Topiramate Augmentation in Treatment-Resistant Obsessive-Compulsive Disorder
Heather A. Berlin et al.
JOURNAL OF CLINICAL PSYCHIATRY (2011)
Rapid Resolution of Obsessions After an Infusion of Intravenous Ketamine in a Patient With Treatment-Resistant Obsessive-Compulsive Disorder
Carolyn I. Rodriguez et al.
JOURNAL OF CLINICAL PSYCHIATRY (2011)
Glutamate abnormalities in obsessive compulsive disorder: Neurobiology, pathophysiology, and treatment
Christopher Pittenger et al.
PHARMACOLOGY & THERAPEUTICS (2011)
Dimensional correlates of poor insight in obsessive-compulsive disorder
Ewgeni Jakubovski et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2011)
A preliminary randomized double-blind clinical trial on the efficacy of celecoxib as an adjunct in the treatment of obsessive-compulsive disorder
Mehdi Sayyah et al.
PSYCHIATRY RESEARCH (2011)
Beneficial psychological effects of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in healthy human volunteers
Michael Messaoudi et al.
GUT MICROBES (2011)
Topiramate Augmentation in Resistant OCD: A Double-Blind Placebo-Controlled Clinical Trial
Arash Mowla et al.
CNS SPECTRUMS (2010)
BARRIERS TO TREATMENT AND SERVICE UTILIZATION IN AN INTERNET SAMPLE OF INDIVIDUALS WITH OBSESSIVE-COMPULSIVE SYMPTOMS
Luana Marques et al.
DEPRESSION AND ANXIETY (2010)
Role of dopamine in the pathophysiology and treatment of obsessive-compulsive disorder
Min-Seong Koo et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2010)
A double-blind, placebo-controlled pilot study of ondansetron for patients with obsessive-compulsive disorder
Farhad Soltani et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2010)
Dimensional predictors of response to SRI pharmacotherapy in obsessive-compulsive disorder
Angeli Landeros-Weisenberger et al.
JOURNAL OF AFFECTIVE DISORDERS (2010)
Minocycline Augmentation of Pharmacotherapy in Obsessive-Compulsive Disorder: An Open-Label Trial
Carolyn I. Rodriguez et al.
JOURNAL OF CLINICAL PSYCHIATRY (2010)
Quality of Life Outcomes in Patients With Obsessive-Compulsive Disorder: Relationship to Treatment Response and Symptom Relapse
Eric Hollander et al.
JOURNAL OF CLINICAL PSYCHIATRY (2010)
A Single-Blinded Case-Control Study of Memantine in Severe Obsessive-Compulsive Disorder
S. Evelyn Stewart et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2010)
Lamotrigine as an augmentation agent in treatment-resistant obsessive-compulsive disorder: a case report
Oe Uzun
JOURNAL OF PSYCHOPHARMACOLOGY (2010)
High-dose selective serotonin reuptake inhibitors in OCD: a systematic retrospective case notes survey
I. Pampaloni et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2010)
The epidemiology of obsessive-compulsive disorder in the National Comorbidity Survey Replication
A. M. Ruscio et al.
MOLECULAR PSYCHIATRY (2010)
Meta-analysis of the dose-response relationship of SSRI in obsessive-compulsive disorder
M. H. Bloch et al.
MOLECULAR PSYCHIATRY (2010)
Obsessive-compulsive disorder with poor insight: A three-year prospective study
Francesco Catapano et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2010)
Sapap3 and Pathological Grooming in Humans: Results From the OCD Collaborative Genetics Study
O. J. Bienvenu et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2009)
Ondansetron Augmentation in Treatment-Resistant Obsessive-Compulsive Disorder A Preliminary, Single-Blind, Prospective Study
Stefano Pallanti et al.
CNS DRUGS (2009)
Double-Blind Study of Dextroamphetamine Versus Caffeine Augmentation for Treatment-Resistant Obsessive-Compulsive Disorder
Lorrin M. Koran et al.
JOURNAL OF CLINICAL PSYCHIATRY (2009)
Memantine Augmentation in Treatment-Resistant Obsessive-Compulsive Disorder An Open-Label Trial
Elias Aboujaoude et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2009)
Anti-Brain Autoantibodies and Altered Excitatory Neurotransmitters in Obsessive-Compulsive Disorder
Sagnik Bhattacharyya et al.
NEUROPSYCHOPHARMACOLOGY (2009)
Evidence for potential relationship between SLC1A1 and a putative genetic linkage region on chromosome 14q to obsessive-compulsive disorder with compulsive hoarding
Kung-Yee Liang et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2008)
Escitalopram in obsessive-compulsive disorder: Response of symptom dimensions to pharmacotherapy
Dan J. Stein et al.
CNS SPECTRUMS (2008)
Clinical implications of insight assessment in obsessive-compulsive disorder
Pino Alonso et al.
COMPREHENSIVE PSYCHIATRY (2008)
Striatal dopamine D-2 receptor availability in OCD with and without comorbid social anxiety disorder: Preliminary findings
Franklin R. Schneier et al.
DEPRESSION AND ANXIETY (2008)
Naltrexone augmentation in OCD: A double-blind placebo-controlled cross-over study
Revital Amiaz et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2008)
High-dose escitalopram for the treatment of obsessive-compulsive disorder
Ilan Rabinowitz et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2008)
Riluzole augmentation in treatment-refractory obsessive-compulsive disorder - A series of 13 cases, with long-term follow-up
Christopher Pittenger et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2008)
In vivo PET study of 5HT2A serotonin and D2 dopamine dysfunction in drug-naive obsessive-compulsive disorder
Daniela Perani et al.
NEUROIMAGE (2008)
Clinical characteristics of schizotypal-related obsessive-compulsive disorder
Michael Poyurovsky et al.
PSYCHIATRY RESEARCH (2008)
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Post-Traumatic Stress Disorders - First Revision
Borwin Bandelow et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2008)
Cortico-striatal synaptic defects and OCD-like behaviours in Sapap3-mutant mice
Jeffrey M. Welch et al.
NATURE (2007)
Effect of comorbid tics on a clinically meaningful response to 8-week open-label trial of fluoxetine in obsessive compulsive disorder
David S. Husted et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2007)
Effects of tryptophan depletion on cognitive functioning, obsessive-compulsive symptoms and mood in obsessive-compulsive disorder: Preliminary results
Anne Katrin Kuelz et al.
NEUROPSYCHOBIOLOGY (2007)
Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder
Francisco A. Moreno et al.
JOURNAL OF CLINICAL PSYCHIATRY (2006)
Memantine augmentation for refractory obsessive-compulsive disorder
Massimo Pasquini et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2006)
A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression
Carlos A. Zarate et al.
ARCHIVES OF GENERAL PSYCHIATRY (2006)
A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder
M. H. Bloch et al.
MOLECULAR PSYCHIATRY (2006)
Clinical features associated with treatment response in obsessive-compulsive disorder
Roseli G. Shavitt et al.
COMPREHENSIVE PSYCHIATRY (2006)
Lack of effects on core obsessive-compulsive symptoms of tryptophan depletion during symptom provocation in remitted obsessive-compulsive disorder patients
A Berney et al.
BIOLOGICAL PSYCHIATRY (2006)
Treatment-refractory obsessive-compulsive disorder: Methodological issues, operational definitions and therapeutic lines
S Pallanti et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2006)
N-acetylcysteine augmentation in serotonin reuptake inhibitor refractory obsessive-compulsive disorder
DL Lafleur et al.
PSYCHOPHARMACOLOGY (2006)
Pulse-loaded intravenous clomipramine in treatment-resistant obsessive-compulsive disorder
LM Koran et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2006)
Mechanism of action of memantine
JW Johnson et al.
CURRENT OPINION IN PHARMACOLOGY (2006)
High-dose sertraline strategy for nonresponders to acute treatment for obsessive-compulsive disorder: A multicenter double-blind tyial
PT Ninan et al.
JOURNAL OF CLINICAL PSYCHIATRY (2006)
Topiramate augmentation in treatment-resistant obsessive-compulsive disorder: A retrospective, open-label case series
M Van Ameringen et al.
DEPRESSION AND ANXIETY (2006)
The effects of topiramate adjunctive treatment added to antidepressants in patients with resistant obsessive-compulsive disorder
Gabriel Rubio et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2006)
Memantine for treatment-resistant OCD
M Poyurovsky et al.
AMERICAN JOURNAL OF PSYCHIATRY (2005)
St John's wort versus placebo in obsessive-compulsive disorder: results from a double-blind study
KA Kobak et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2005)
Glutamatergic dysfunction in OCD
K Chakrabarty et al.
NEUROPSYCHOPHARMACOLOGY (2005)
Riluzole augmentation in treatment-resistant obsessive-compulsive disorder: An open-label trial
V Coric et al.
BIOLOGICAL PSYCHIATRY (2005)
Can a subgroup of OCD patients with motor abnormalities and poor therapeutic response be identified?
R Mergl et al.
PSYCHOPHARMACOLOGY (2005)
Magnitude of placebo response and drug-placebo differences across psychiatric disorders
A Khan et al.
PSYCHOLOGICAL MEDICINE (2005)
Mirtazapine for obsessive-compulsive disorder: An open trial followed by double-blind discontinuation
LM Koran et al.
JOURNAL OF CLINICAL PSYCHIATRY (2005)
Double-blind treatment with oral morphine in treatment-resistant obsessive-compulsive disorder
LM Koran et al.
JOURNAL OF CLINICAL PSYCHIATRY (2005)
The use of dextromethorphan to treat repetitive self-directed scratching, biting, or chewing in dogs with allergic dermatitis
NH Dodman et al.
JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS (2004)
Overvalued ideation as a predictor of fluvoxamine response in patients with obsessive-compulsive disorder
F Neziroglu et al.
PSYCHIATRY RESEARCH (2004)
Do antipsychotics ameliorate or exacerbate obsessive compulsive disorder symptoms? A systematic review
J Sareen et al.
JOURNAL OF AFFECTIVE DISORDERS (2004)
Low level of dopaminergic D2 receptor binding in obsessive-compulsive disorder
D Denys et al.
BIOLOGICAL PSYCHIATRY (2004)
Response acceleration with mirtazapine augmentation of citalopram in obsessive-compulsive disorder patients without comorbid depression: A pilot study
S Pallanti et al.
JOURNAL OF CLINICAL PSYCHIATRY (2004)
Obsessive-compulsive symptoms induced by atypical antipsychotics. A review of the reported cases
L Lykouras et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2003)
Beneficial effects of the antiglutamatergic agent riluzole in a patient diagnosed with obsessive-compulsive disorder and major depressive disorder
V Coric et al.
PSYCHOPHARMACOLOGY (2003)
Methylphenidate elevates resting dopamine which lowers the impulse-triggered release of dopamine: a hypothesis
P Seeman et al.
BEHAVIOURAL BRAIN RESEARCH (2002)
Obsessive-compulsive disorder with poor insight
H Matsunaga et al.
COMPREHENSIVE PSYCHIATRY (2002)
Predictors of response to pharmacotherapy with citalopram in obsessive-compulsive disorder
DJ Stein et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2001)
Insight and treatment outcome in obsessive-compulsive disorder
JL Eisen et al.
COMPREHENSIVE PSYCHIATRY (2001)
Adults with early-onset obsessive-compulsive disorder
MC do Rosario-Campos et al.
AMERICAN JOURNAL OF PSYCHIATRY (2001)
Minocycline provides neuroprotection against N-methyl-D-aspartate neurotoxicity by inhibiting microglia
TM Tikka et al.
JOURNAL OF IMMUNOLOGY (2001)
Insight and resistance in patients with obsessive-compulsive disorder
F Catapano et al.
PSYCHOPATHOLOGY (2001)
The effect of the NMDA receptor blocker, dextromethorphan, on cribbing in horses
RA Rendon et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2001)
Glutamatergic drugs exacerbate symptomatic behavior in a transgenic model of comorbid Tourette's syndrome and obsessive-compulsive disorder
MJ McGrath et al.
BRAIN RESEARCH (2000)
Lamotrigine augmentation of serotonin re-uptake inhibitors in obsessive-compulsive disorder
TCR Kumar et al.
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2000)
Pindolol augmentation in treatment-resistant obsessive compulsive disorder: a double-blind placebo controlled trial
PN Dannon et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2000)
Antidepressant effects of ketamine in depressed patients
RM Berman et al.
BIOLOGICAL PSYCHIATRY (2000)
Decrease in caudate glutamatergic concentrations in pediatric obsessive-compulsive disorder patients taking paroxetine
DR Rosenberg et al.
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY (2000)
分享论文
